[1]李 征,米登海,杨克虎,等.经动脉化疗栓塞联合微波消融治疗肝癌有效性和安全性的系统评价[J].介入放射学杂志,2015,(11):957-963.
 LI Zheng,MI Deng- hai,YANG Ke- hu,et al.Effectiveness and safety of TACE combined with MWA for primary hepatic cancer: a systematic review[J].journal interventional radiology,2015,(11):957-963.
点击复制

经动脉化疗栓塞联合微波消融治疗肝癌有效性和安全性的系统评价 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2015年11期
页码:
957-963
栏目:
肿瘤介入
出版日期:
2015-11-25

文章信息/Info

Title:
Effectiveness and safety of TACE combined with MWA for primary hepatic cancer: a systematic review
作者:
李 征 米登海 杨克虎 曹 农 田金徽 马 彬 拜争刚
Author(s):
LI Zheng MI Deng- hai YANG Ke- hu CAO Nong TIAN Jin- hui MA Bin BAI Zheng- gang
First Clinical Medical College of Lanzhou University, Lanzhou, Gansu Province 730000, China
关键词:
【关键词】 肝癌 微波消融 经导管动脉化疗栓塞术 系统评价 Meta分析 随机对照试验
文献标志码:
A
摘要:
【摘要】 目的 评价经导管动脉化疗栓塞术(TACE)联合微波消融(MWA)治疗原发性肝癌的有效性及安全性,为临床实践与研究提供参考。方法 计算机检索Cochrane Library、PubMed、EMbase、Web of Science、CBM、CNKI、WanFang及VIP 8个数据库,同时辅以其他检索,收集所有TACE联合MWA治疗原发性肝癌的随机对照试验(RCT)。评价员按照研究计划书进行文献筛选和资料提取,并对纳入文献进行质量评价后,使用RevMan 5.3软件进行Meta分析。结果 共纳入19篇RCT(1 356例患者)。Meta分析结果显示:①联合组0.5年、1年、1.5年、2年和3年的总生存率均明显好于TACE组,且其差异均有统计学意义(P<0.05);合并结果分别为0.5年[RR=1.24,95%CI=(1.12,1.37)],1年[RR=1.50,95%CI=(1.38,1.62)],1.5年[RR=2.05,95%CI=(1.38,3.06)],2年[RR=1.97,95%CI=(1.65,2.36)],3年[RR=3.39, 95%CI=(2.32,4.96)]。②联合组的完全缓解率、总有效率、完全坏死率和甲胎蛋白(AFP)的转阴率均高于单独TACE组,联合组的复发率低于单独TACE组,且其差异均有统计学意义(P<0.05);合并结果分别为完全缓解率[RR=2.53,95%CI=(1.45,4.41)],总有效率[RR=1.69, 95%CI=(1.43,1.99)],完全坏死率[RR=2.51,95%CI=(1.87,3.36)],AFP转阴率[RR=1.49, 95%CI=(1.28,1.73)],复发率[RR=0.28, 95%CI=(0.15,0.52)]。结论 相比较单用TACE治疗,TACE联合MWA治疗原发性肝癌能提高患者近期疗效和远期生存率,降低复发率,且安全性仍较好。

参考文献/References:

[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65: 87- 108.
[2] Meng MB, Cui YL, Lu Y, et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta- analysis[J]. Radiother Oncol, 2009, 92: 184- 194.
[3] 吴孟超, 陈 汉, 沈 锋, 等. 微创在肝癌外科治疗中的地位[J]. 中国微创外科杂志, 2002, 2: 69- 70.
[4] 陈 谦, 李 强. 原发性肝癌介入治疗的研究进展[J]. 中国肿瘤临床, 2006, 33: 654- 657.
[5] Fesenko EE, Makar VR, Novoselova EG, et al. Microwaves and cellular immunity I. Effect of whole body microwave irradiation on tumor necrosis factor production in mouse cells[J]. Bioelect- rochem Bioenerg, 1999, 49: 29- 35.
[6] 张 晶, 董宝玮, 梁 萍, 等. 原发性肝癌经皮微波凝固治疗前后局部免疫活性细胞功能检测[J]. 中华医学杂志, 2001, 81: 974- 977.
[7] Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0[DB/OL]. http://www.cochrane- handbook.org.
[8] Yi Y, Zhang Y, Wei Q, et al. Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone[J]. Chin J Cancer Res, 2014, 26: 112- 118.
[9] 张世杰, 马亦龙. 经导管动脉化疗栓塞术联合经皮微波消融治疗大肝癌[J]. 中国介入影像与治疗学, 2013, 10: 397- 400.
[10] 陈 刚, 唐晓军, 李宏波, 等. 肝动脉化疗栓塞联合经皮微波消融治疗中晚期肝癌的疗效评价[J]. 临床放射学杂志, 2012, 31: 710- 713.
[11] 马文静, 郭双双, 张立成, 等. 肝动脉化疗栓塞联合微波消融治疗肝癌的临床研究[J]. 中国现代医药杂志, 2012, 14: 28- 30.
[12] 孙 茂, 牟洪超, 周 辉. 肝动脉化疗栓塞联合经皮微波凝固治疗原发性肝癌[J]. 实用医药杂志, 2012, 29: 413- 414.
[13] 杨广辉, 韩正祥, 胡春峰. 肝动脉灌注化疗栓塞联合经皮穿刺瘤内微波凝固治疗原发性肝癌[J]. 江苏医药, 2012, 38: 1535- 1537.
[14] 郑爱民, 叶 欣, 杨 霞, 等. 微波消融联合肝动脉栓塞化疗治疗肝癌46例分析[J]. 医学影像学杂志, 2012, 22: 1692- 1695.
[15] 段巨涛, 孔 棣, 柴友龙. 经肝动脉栓塞化疗联合微波刀治疗中晚期肝癌的临床疗效分析[J]. 中国肿瘤临床, 2011, 38: 1283- 1286.
[16] Liu C, Liang P, Liu F, et al. MWA combined with TACE as a combined therapy for unresectable large- sized hepotocellular carcinoma[J]. Int J Hyperthermia, 2011, 27: 654- 662.
[17] 邱少敏, 陈 刚, 李宏波. 肝动脉化疗栓塞联合经皮微波凝固疗法治疗中晚期肝癌的临床观察[J]. 现代医学, 2011, 39: 526- 529.
[18]韦忠恒, 陆建勋, 浦 涧, 等. 肝动脉化疗栓塞联合微波消融治疗复发性肝癌的研究[J]. 广西医学, 2011, 33: 1131- 1132.
[19] 徐永茂, 徐冬云, 张南征, 等. 肝动脉栓塞化疗联合冷循环微波凝固治疗大肝癌40例[J]. 东南国防医药, 2011, 13: 446- 447.
[20] 张崇高, 王国林. 肝动脉化疗栓塞联合微波消融治疗原发性肝癌临床疗效分析[J]. 实用肝脏病杂志, 2011, 14: 378- 379.
[21] 周培华, 邓和军, 许国辉, 等. TACE联合PMCT治疗中晚期肝癌的临床观察[J]. 肿瘤预防与治疗, 2009, 22: 294- 296.
[22] 陆骊工, Hu BS, 李 勇, 等. 微波消融联合TACE治疗原发性肝癌的临床研究[J]. 实用放射学杂志, 2008, 24: 957- 959, 979.
[23] 向 华, 龙 林, 张智明, 等. 联合介入治疗大肝癌的临床疗效分析[J]. 南华大学学报?医学版, 2007, 35: 761- 763.
[24] 许林锋, 陈耀庭, 任 强, 等. TACE联合冷循环PMCT治疗原发性肝癌的临床应用[J]. 中国肿瘤临床, 2007, 34: 553- 557.
[25] 马善芝, 陈 民. 肝动脉化疗栓塞及经皮微波凝固联合治疗巨块型肝癌的护理[J]. 哈尔滨医药, 2006, 26: 89- 90.
[26] 金诗湘. 肝动脉栓塞化疗联合微波凝固治疗原发性肝癌疗效分析[J]. 中国基层医药, 2005, 12: 603- 604.
[27] Lee HS, Kim JS, Choi IJ, et al. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study[J]. Cancer, 1997, 79: 2087- 2094.
[28] Bruix J, Llovet JM, Castells A, et al. Transarterial embolization?carcinoma: results of a randomized, controlled trial in a single institution[J]. Hepatology, 1998, 27: 1578- 1583.
[29] 李 征, 米登海, 杨克虎, 等. 肝动脉化疗栓塞术联合氩氦刀治疗肝癌疗效及安全性的系统评价[J]. 中国循证医学杂志, 2013, 13: 31- 38.
[30] 李 征, 米登海, 杨克虎, 等. 介入化疗栓塞术联合热疗治疗原发性肝癌的Meta分析[J]. 中国循证医学杂志, 2012, 12: 672- 678.
[31] 经 翔, 丁建民, 王彦冬, 等. 射频消融和微波消融治疗肝癌的比较[J]. 介入放射学杂志, 2014, 23: 306- 310.
[32] Xu LF, Sun HL, Chen YT, et al. Large primary hepatocellular carcinoma: Transarterial chemoembolization monotherapy versus combined transarterial chemoembolization- percutaneous microwave coagulation therapy[J]. J Gastroenterol Hepatol, 2013, 28: 456- 463.
[33] Bhardwaj N, Dormer J, Ahmad F, et al. Microwave ablation of the liver: a description of lesion evolution over time and an investigation of the heat sink effect[J]. Pathology, 2011, 43: 725- 731.
[34] 许 伟, 顾玉明, 王兴田, 等. 超声造影引导下微波消融联合TACE治疗肝转移瘤[J]. 介入放射学杂志, 2012, 21: 821- 824.
[35] Liu Z, Ahmed M, Weinstein Y, et al. Characterization of the RF ablation- induced‘oven effect’: the importance of background tissue thermal conductivity on tissue heating[J]. Int J Hyperthermia, 2006, 22: 327- 342.
[36] 万豪光, 许 伟, 徐 浩, 等. 经导管化疗栓塞联合经皮微波消融治疗中晚期肝癌64例的预后分析[J]. 介入放射学杂志, 2014, 23: 477- 481.
[37] 宗迎迎, 徐 浩, 许 伟, 等. 经肝动脉化疗栓塞联合经皮微波消融序贯治疗早期肝癌的疗效及预后影响因素[J]. 介入放射学杂志, 2015, 24: 210- 214.
[38] 钟 敏, 宁竹之, 刘本禄. 微波热凝固对肿瘤杀伤及免疫效应的实验研究[J]. 中华理疗杂志, 1997, 20: 16- 18.
[39] 韩秀婕, 董宝玮, 梁 萍, 等. 微波治疗肝癌后局部细胞免疫变化及其对临床疗效影响[J]. 中国癌症杂志, 2007, 17: 135- 138.
[40] 张春淼, 何 晶, 张艳霞, 等. CT引导经皮穿刺微波消融治疗原发性肝癌的护理[J]. 介入放射学杂志, 2015, 24: 265- 267.
[41] 苏晓妹, 朱亚杰, 张 涛, 等. 超声下微波治疗肝功能分级差的小肝癌[J]. 介入放射学杂志, 2012, 21: 825- 828.
[42] 杨业发, 伍 路, 申淑群, 等. 胆管冷却技术在中央胆管旁肝癌微波消融术中的应用[J]. 介入放射学杂志, 2014, 23: 1048- 1051.

相似文献/References:

[1]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
 .The volume of Lipiodol used in TACE: its current situation and research progress [J].journal interventional radiology,2012,(11):348.
[2]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
 ,,et al.TACE combined with radiofrequency ablation for massive primary hepatocellular carcinomas: a clinical therapeutic evaluation [J].journal interventional radiology,2012,(11):322.
[3]李晓峰,钱国军,张 磊,等. 微波高功率条件下消融原发性肝癌的初步研究[J].介入放射学杂志,2011,(12):974.
 LI Xiao-feng,QIAN Guo-jun,ZHANG Lei,et al.Microwave ablation with high output power for the treatment of hepatocellular carcinoma: a preliminary study[J].journal interventional radiology,2011,(11):974.
[4]张   磊,陆骊工,李   勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
 ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(11):968.
[5]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
 AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(11):1010.
[6]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
 DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(11):75.
[7]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
 ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(11):78.
[8]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
 HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(11):682.
[9]罗中华,秦 勉,张学昕,等.原发性肝癌合并下腔静脉及右心房癌栓的动脉内化疗栓塞治疗[J].介入放射学杂志,2012,(12):1035.
 LUO Zhong? hua,QIN Mian,ZHANG Xue? xin,et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma complicated by tumor thrombus in inferior vena cava and right atrium[J].journal interventional radiology,2012,(11):1035.
[10]徐 阳,臧 爽,陈路锋,等.Logistic回归及ROC曲线综合评价血生化指标对肝癌TACE术后发热的预测价值 [J].介入放射学杂志,2013,(06):513.
 XU Yang,ZANG Shuang,CHEN Lu? feng,et al. Combination evaluation of plasma biochemical indexes with Logistic regression and ROC analysis in predicting hyperthermia after transcatheter hepatic arterial chemoembolization for liver cancer[J].journal interventional radiology,2013,(11):513.
[11]韦 伟,关利君.TACE联合微波消融与联合125I放射性粒子植入治疗不可切除肝癌合并门静脉癌栓疗效比较[J].介入放射学杂志,2022,31(09):889.
 WEI Wei,GUAN Lijun..TACE combined with microwave ablation and 125I radioactive seed implantation for the treatment of inoperable liver cancer with portal vein tumor thrombus[J].journal interventional radiology,2022,31(11):889.

备注/Memo

备注/Memo:
(收稿日期:2015-03-03)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2015-11-24